Biomedical Engineering Reference
In-Depth Information
3. Hale MB, Nolan GP. Phospho-specific flow cytometry: intersection of immunology and
biochemistry at the single-cell level. Curr. Opin. Mol. Ther. 2006;8:215-224.
4. Irish JM, Kotecha N, Nolan GP. Mapping normal and cancer cell signalling networks:
towards single-cell proteomics. Nat. Rev. Cancer 2006;6:146-155.
5. Danna EA, Nolan GP. Transcending the biomarker mindset: deciphering disease
mechanisms at the single cell level. Curr. Opin. Chem. Biol. 2006;10:20-27.
6. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow
cytometry: monitoring single cell signaling events. Cytometry A 2003;55:61-70.
7. Kotecha N, Flores NJ, Irish JM, Simonds EF, Sakai DS, Archambeault S, Diaz-Flores E,
Coram M, Shannon KM, Nolan GP, Loh ML. Single-cell profiling identifies aberrant
STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.
Cancer Cell 2008;14:335-343.
8. Hale MB, Krutzik PO, Samra SS, Crane JM, Nolan GP. Stage dependent aberrant
regulation of cytokine-STAT signaling in murine systemic lupus erythematosus. PLoS
One 2009;4:e6756.
9. Tanabe Y, Nishibori T, Su L, Arduini RM, Baker DP, David M. Cutting edge: role of
STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J. Immunol.
2005;174:609-613.
10. Krutzik PO, Nolan GP. Fluorescent cell barcoding in flow cytometry allows high-
throughput drug screening and signaling profiling. Nat. Methods 2006;3:361-368.
11. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation
and validation of high throughput screening assays. J. Biomol. Screen. 1999;4:67-73.
12. Sklar LA, Carter MB, Edwards BS. Flow cytometry for drug discovery, receptor
pharmacology and high-throughput screening. Curr. Opin. Pharmacol. 2007;7:527-534.
13. Edwards BS, Young SM, Ivnitsky-Steele I, Ye RD, Prossnitz ER, Sklar LA. High-content
screening: flow cytometry analysis. Methods Mol. Biol. 2009;486:151-165.
14. Edwards BS, Oprea T, Prossnitz ER, Sklar LA. Flow cytometry for high-throughput, high-
content screening. Curr. Opin. Chem. Biol. 2004;8:392-398.
15. Arterburn JB, Oprea TI, Prossnitz ER, Edwards BS, Sklar LA. Discovery of selective
probes and antagonists for G-protein-coupled receptors FPR/FPRL1 and GPR30. Curr.
Top. Med. Chem. 2009;9:1227-1236.
16. Krutzik PO, Crane JM, Clutter MR, Nolan GP. High-content single-cell drug screening
with phosphospecific flow cytometry. Nat. Chem. Biol. 2008;4:132-142.
17. O'GormanWE, Dooms H, Thorne SH, KuswantoWF, Simonds EF, Krutzik PO, NolanGP,
Abbas AK. The initial phase of an immune response functions to activate regulatory T
cells. J. Immunol. 2009;183:332-339.
18. Hotson AN, Hardy JW, Hale MB, Contag CH, Nolan GP. The T cell STAT signaling
network is reprogrammed within hours of bacteremia via secondary signals. J. Immunol.
2009;182:7558-7568.
19. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, Gjertsen BT, Nolan GP. Single
cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004;118:
217-228.
20. Krutzik PO, Clutter MR, Nolan GP. Coordinate analysis of murine immune cell surface
markers and intracellular phosphoproteins by flow cytometry. J. Immunol. 2005;175:
2357-2365.
Search WWH ::
Custom Search